Anti-HIV agents. New drugs, new hope, old lessons.
D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines / Q000009:adverse effects; D065100:CCR5 Receptor Antagonists; D018791:CD4 Lymphocyte Count; D003510:Cyclohexanes / Q000627:therapeutic use; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced; D000077592:Maraviroc; D009930:Organic Chemicals / Q000627:therapeutic use; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D014230:Triazoles / Q000627:therapeutic use; D019562:Viral Load
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes; D003521:Cyclopropanes; D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D014230:Triazoles; D000068898:Raltegravir Potassium; C098320:efavirenz; D000077592:Maraviroc